课题基金 / 基金详情

项目摘要

项目成果

BARBARA BOWLES BIESECKER的其他基金

相似基金

相关文献

中文摘要
翻译
在过去的一年里,遗传学服务研究单位的调查人员一直在NHGRI的两个研究倡议:Multiplex Initiative和ClinSeq中进行遗传咨询相关研究。 两项研究利用了在密歇根州底特律的一个大型医疗保健系统内进行的多元计划中新基因技术的可用性。所有参与者都接受了一项多重基因测试,评估了八种疾病的风险:2型糖尿病、骨质疏松症、高血压、冠心病、高胆固醇血症、皮肤癌、肺癌和结直肠癌。我们的目的是了解参与者对选择性返回结果的假设兴趣,因为人们在多疾病测试的条件中进行选择时的偏好知之甚少。在这项辅助研究中,294名健康的参保参与者接受了多重基因测试。数据是在基线、决策和测试期间收集的。一项分析侧重于了解人们如何整合对多种健康状况的态度,以做出关于基因检测摄取的决定。不同疾病的平均态度预测了检测摄入量,但除了峰值态度之外,并没有贡献,峰值态度是对单一疾病检测的最高态度。这些发现支持了人们在态度形成过程中使用代表性评价的理论。这些发现对基因检测的进一步发展的暗示是,多重检测的沟通和影响可能需要考虑到对高峰态度的偏见。另一项分析评估了担忧与对八种常见疾病的可能性和严重性的看法之间的关系。检查了个体和疾病在忧虑和知觉上的变异性。受试者之间和受试者内部的分析得出了以下主要发现:(1)担忧与可能性知觉的关系比与严重性知觉的关系更密切;(2)严重性知觉显著增加了高于可能性知觉的可解释的担忧差异;(3)风险感知和担忧形成了两个簇:癌症疾病和心血管代谢疾病;(4)风险感知和担忧的差异是由受试者之间和受试者内部的差异共同解释的。风险感知研究应该关注严重性感知、受试者内部的可变性和疾病间的差异,以及分组情况的策略。 结合美国国立卫生研究院的临床全基因组测序研究,我们探索了参与者对接收不同类型的测序结果的偏好。我们对NIH ClinSeq队列研究参与者进行了一项基线调查,以评估不确定性的感知,假设不确定性是学习和使用序列信息的关键决定因素。我们基于不确定性的理论工作和对研究参与者的焦点小组访谈,开发了一种新的量表,用于评估基因组测序特有的不确定性感知。该量表包含10个项目,评估与基因组序列结果相关的不确定性对一个人未来健康和行动的预测影响的感知。473名ClinSeq参与者在决定是否学习他们的序列结果之前完成了这一量表。回答符合正态分布,总体平均不确定度分数为3.5SD0.58,内部一致性较高(=0.835)。验证性因素分析揭示了与实际不确定性、情感反应和结果可信度有关的三个因素。未来在这项纵向研究中使用这一量表将使我们能够确定不确定性感知随时间的变化,以及不确定性感知如何影响关于学习和行动的决定,并根据序列结果采取行动。
英文摘要
Over the past year, the Genetics Services Research Unit investigators have been conducting genetic counseling related research within two NHGRI research initiatives: The Multiplex Initiative and ClinSeq. Two studies capitalized on the availability of new genetic technology within the Multiplex Initiative that was conducted within a large health care system in Detroit, Michigan. All participants were offered a multiplex genetic test that assessed risk for eight conditions: type 2 diabetes, osteoporosis, hypertension, coronary heart disease, hypercholesterolemia, skin cancer, lung cancer and colorectal cancer. We aimed to understand participants hypothetical interest in selective return of results as little is known about peoples preferences when choosing among conditions on a multi-disease test. In this ancillary study, 294 healthy insured participants were offered multiplex genetic testing. Data was collected at baseline, during decision-making, and testing. One analysis focused on learning how people integrate attitudes about multiple health conditions to make a decision about genetic testing uptake. Averaging attitudes across diseases predicted test uptake but did not contribute beyond peak attitudes, the highest attitude toward testing for a single disease in the set. Peak attitudes were found sufficient to predict test uptake.These findings support theories suggesting that people use representative evaluations in attitude formation. The implication of these findings for further developments in genetic testing is that the communication and impact of multiplex testing may need to be considered in the light of a bias toward peak attitudes. Another analysis assessed the relationships between worry and perceptions of likelihood and severity across the eight common diseases. Individual and disease variability in worry and perceptions were examined. Between- and within-subjects analyses yielded the following main findings: (1) worry is more closely related to likelihood perceptions than to severity perceptions; (2) severity perceptions add significantly to explained worry variances above and beyond likelihood perceptions; (3) risk perceptions and worries form two clusters: cancer diseases and cardiovascular-metabolic diseases; and (4) variance in risk perception and worry is explained by a combination of between- and within-subjects variances. Risk perception research should attend to severity perceptions, within-subjects variability and inter-disease differences, and to strategies for grouping conditions. In conjunction with an NIH clinical whole genome sequencing study we explored participants preferences for the receipt of different types of their sequence results. We conducted a baseline survey of NIH ClinSeq cohort study participants to assess perceptions of uncertainty, hypothesized to be a key determinant of decisions to learn and use sequence information. We developed a novel scale assessing perceptions of uncertainty specific to genomic sequencing, based on theoretical work on uncertainty and focus groups interviews with study participants. The scale contains 10 items that assess perceptions of the projected effect of uncertainties related to genomic sequence results on ones future health and actions. 473 ClinSeq participants completed the scale prior to making a decision about whether to learn their sequence results. There was a normal distribution in responses with an overall mean uncertainty score of 3.5 (SD 0.58) and high internal consistency (α=0.835). Confirmatory factor analysis revealed three factors related to practical uncertainty, affective responses and trustworthiness of the results. Future use of this scale within this longitudinal study will allow us to identify changes in perceptions of uncertainty over time and how perceptions of uncertainty affect decisions about learning and acting on ones sequence results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Access to Genetic Information Leveraging Innovative Technology (AGILITY) Study
  • 批准号:
    10292565
  • 项目类别:
  • 资助金额:
    $43.42万
  • 财政年份:
    2021
  • 负责人:
    BARBARA BOWLES BIESECKER
  • 依托单位:
CONFERENCE ON HUMAN GENOME RESEARCH IMPLICTIONS
Stigma/culture/genetics of schizophrenia--Family perspec
Language Interpreters in Genetic Counseling
海外基金